Charles E. Richardson - 29 Jul 2022 Form 4 Insider Report for Icosavax, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Aug 2022, 21:40:32 UTC
Prior SEC filing
16 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact

Key filing fact

Charles E. Richardson filed Form 4 for Icosavax, Inc. on 02 Aug 2022.

Key facts

  • This page summarizes Charles E. Richardson's Form 4 filing for Icosavax, Inc..
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Aug 2022, 21:40.

Change

  • Previous filing in this sequence was filed on 16 Feb 2022.
  • Current net transaction value: -$14,972.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICVX transaction

Common Stock

Sale

Transaction value
$3,405
Shares
-479
Change %
-0.29%
Price
$7.11
Shares after
166,907
Date
29 Jul 2022
Ownership
Direct
Footnotes
F1, F2
ICVX transaction

Common Stock

Sale

Transaction value
$9,080
Shares
-1,368
Change %
-0.82%
Price
$6.64
Shares after
165,539
Date
01 Aug 2022
Ownership
Direct
Footnotes
F1, F3
ICVX transaction

Common Stock

Sale

Transaction value
$2,487
Shares
-371
Change %
-0.22%
Price
$6.70
Shares after
165,168
Date
02 Aug 2022
Ownership
Direct
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents shares withheld by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover the applicable withholding taxes upon settlement of restricted stock units issued to the Reporting Person.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.93 to $7.75. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.38 to $7.17. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.460 to $6.865. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .